Play

Play Overview Evidence Contributors

Favorites

Thrombocytopenia Features

Type of heparin-induced thrombocytopenia (HIT) onset suspected

Typical-onset HIT: Platelet count begins to fall within 5-10 days after starting heparin.
Rapid-onset HIT: Platelet count begins to fall within 24 hours of starting heparin, strongly associated with recent (in last 100 days) heparin exposure.

TypicalRapid

Introduction

The HEP Score is a pretest clinical scoring model for heparin-induced thrombocytopenia (HIT), a rapid, life-threatening adverse drug reaction to heparin exposure. The HEP score is a tool that can potentially aid in diagnosing patients with suspected HIT, and to avoid expensive HIT workups in some patients. It was developed specifically to address a known weakness of the 4Ts Score: significant inter-observer variability and subjectivity, particularly in its "other causes of thrombocytopenia" criterion. Rather than being derived from a single research group's clinical experience, the HEP Score was built from the collective input of 26 HIT experts, making it the first HIT scoring system grounded in broad expert consensus rather than one institution's data. One caveat worth noting: the developers themselves noted that larger studies of the HEP score are likely necessary prior to broader independent implementation — it hasn't achieved quite the same multi-institution validation base as the 4Ts.

How It's Scored

Unlike the 4Ts' simple 0–2-per-category structure, the HEP Score is more granular — 8 clinical features potentially important in the diagnosis of HIT are weighted, each contributing positive or negative points. Questions and choices are displayed based on the type of heparin-induced thrombocytopenia (HIT) onset suspected (typical v. rapid). For example, the timing of platelet count fall for a typical HIT onset will display 5 choices as shown below and 2 choices will display for a rapid HIT onset.

Variable	Points
Thrombocytopenia Features
Magnitude of fall in platelet count (peak platelet count to nadir since heparin)	<30%	-1
30-50%	1
>50%	3
Timing of platelet count fall for patients in whom typical HIT onset is suspected	Fall begins <4 days after heparin exposure	-2
Fall begins 4 days after heparin exposure	2
Fall begins 5-10 days after heparin exposure	3
Fall begins 11-14 days after heparin exposure	2
Fall begins >14 days after heparin exposure	-1
Timing of platelet count fall for patients with prior heparin exposure (last 100 days) in whom rapid HIT onset is suspected	Fall begins <48 hours after heparin re-exposure	2
Fall begins >48 hours after heparin re-exposure	-1
Nadir platelet count	≤20 × 10⁹/L	-2
>20 × 10⁹/L	2
Thrombosis for patients in whom typical HIT onset is suspected	New VTE or ATE ≥4 days after heparin exposure	3
Progression of pre-existing VTE or ATE while receiving heparin	2
None	0
Thrombosis for patients with prior heparin exposure (last 100 days) in whom rapid HIT onset is suspected	New VTE or ATE after heparin exposure	3
Progression of pre-existing VTE or ATE while receiving heparin	2
None	0
Skin necrosis at subcutaneous heparin injection sites	No	0
Yes	3
Acute systemic reaction after IV heparin bolus	No	0
Yes	2
Presence of bleeding, petechiae or extensive bruising	No	0
Yes	-1
Other Causes of Thrombocytopenia
Presence of chronic thrombocytopenic disorder	No	0
Yes	-1
Newly initiated non-heparin medication known to cause thrombocytopenia	No	0
Yes	-1
Severe infection	No	0
Yes	-2
Severe DIC (fibrinogen <100 mg/dL and D-dimer >5 µg/mL)	No	0
Yes	-2
Indwelling intra-arterial device (e.g. IABP, VAD, ECMO)	No	0
Yes	-2
Cardiopulmonary bypass within previous 96 hours	No	0
Yes	-1
No other apparent cause	No	0
Yes	3

Interpretation: A cutoff score of ≥2 was found to be 100% sensitive and 60–76% specific (specificity varies slightly by validation study) for a diagnosis of HIT as defined by the expert panel — meaning the HEP Score is designed to function primarily as a highly sensitive rule-out tool, similar in philosophy to the 4Ts' strength at the low end. This was superior to the 4Ts for HIT Score. Further, it was noted that a cut off of 5 would maximize sensitivity/specificity at 86% and 88%, respectively, in the cohort of patients analyzed, although its utility as a clinical decision tool is lessened with this cut-off.

How It Compares to the 4Ts Score

Inter-observer agreement: The original validation study found a trend toward significantly greater inter-observer agreement (intraclass correlation coefficient) with HEP versus 4Ts — directly addressing the reliability problem I flagged with the 4Ts in my last answer.
Sensitivity/specificity tradeoff: In external validation, a HEP score ≥2 was 100% sensitive but only 16% specific, while a 4Ts score >3 was 93% sensitive with better specificity — so HEP trades some specificity for a small sensitivity gain and better consistency between raters.
Complexity tradeoff: HEP is more granular (8 items, positive/negative weighting, wider score range) versus the 4Ts' simpler 4-item, 0–2-point structure — this added granularity is likely why it achieves better inter-rater agreement, but it also makes it a more complex build.

All questions & possible results

Thrombocytopenia Features

Type of heparin-induced thrombocytopenia (HIT) onset suspected

Typical-onset HIT: Platelet count begins to fall within 5-10 days after starting heparin.
Rapid-onset HIT: Platelet count begins to fall within 24 hours of starting heparin, strongly associated with recent (in last 100 days) heparin exposure.

Select one option:

Typical
Rapid

Magnitude of platelet count fall Peak to nadir count since heparin

Select one option:

<30%
30-50%
>50%

Timing of platelet count fall

Select one option:

Fall beigns <4 days after heparin exposure
Fall begins 4 days after heparin exposure
Fall begins 5-10 days after heparin exposure
Fall begins 11-14 days after heparin exposure
Fall begins >14 days after heparin exposure

Timing of platelet count fall (Rapid)

Select one option:

Fall beigns <48 hours after heparin re-exposure
Fall beigns >48 hours after heparin re-exposure

Nadir platelet count

Select one option:

≤20 x 10⁹/L
>20 x 10⁹/L

Thrombosis

Select one option:

New venous thromboembolism (VTE) or arterial thromboembolism (ATE) ≥4 days after heparin exposure
Progression of pre-existing VTE or ATE while receiving heparin
None

Skin necrosis at subcutaneous heparin injection sites

Select one option:

Acute systemic reaction after IV heparin bolus

Select one option:

Presence of bleeding, petechiae or extensive bruising

Select one option:

Other Causes of Thrombocytopenia

Presence of chronic thrombocytopenic disorder

Select one option:

Newly initiated non-heparin medication known to cause thrombocytopenia

Select one option:

Severe infection

Select one option:

Severe disseminated intravascular coagulation (DIC) Fibrinogen <100 mg/dL and D-dimer >5 µg/mL

Select one option:

Indwelling intra-arterial device IABP, VAD, ECMO

Intra-arterial balloon pump (IABP)
Ventricular assist device (VAD)
Extra-corporeal membrane oxygenation (ECMO)

Select one option:

Cardiopulmonary bypass within previous 96 hours

Select one option:

No other apparent cause

Select one option:

Possible results

HEP Scores ≥2 are 100% sensitive for HIT

Consider using the 4Ts scoring system in conjunction with the HEP score as an alternative evaluation tool prior to time-consuming antibody testing for HIT or empiric substitution of heparin for another anti-coagulant.
Consider further laboratory evaluation for HIT or switching to a non-heparin derived anti-coagulant in those patients that are above the screening threshold for HIT based on their HEP score.

HEP Score suggests a lower probability of HIT (Scores <2)

Consider using the 4Ts scoring system in conjunction with the HEP score as an alternative evaluation tool prior to time-consuming antibody testing for HIT or empiric substitution of heparin for another anti-coagulant.
Consider further laboratory evaluation for HIT or switching to a non-heparin derived anti-coagulant in those patients that are above the screening threshold for HIT based on their HEP score.

Citation

Cuker A, Arepally G, Crowther MA, Rice L, Datko F, Hook K, Propert KJ, Kuter DJ, Ortel TL, Konkle BA, Cines DB. The HIT Expert Probability (HEP) Score: a novel pre-test probability model for heparin-induced thrombocytopenia based on broad expert opinion. J Thromb Haemost. 2010 Dec;8(12):2642-50.

Literature

Cuker A, Arepally G, Crowther MA, Rice L, Datko F, Hook K, Propert KJ, Kuter DJ, Ortel TL, Konkle BA, Cines DB. The HIT Expert Probability (HEP) Score: a novel pre-test probability model for heparin-induced thrombocytopenia based on broad expert opinion. J Thromb Haemost. 2010 Dec;8(12):2642-50.
https://pubmed.ncbi.nlm.nih.gov/20854372/
Joseph L, Gomes MP, Al Solaiman F, St John J, Ozaki A, Raju M, Dhariwal M, Kim ES. External validation of the HIT Expert Probability (HEP) score. Thromb Haemost. 2015 Mar;113(3):633-40.
https://pubmed.ncbi.nlm.nih.gov/25588983/

Thrombocytopenia Features

All questions & possible results

Citation

Literature

Related evaluations

4Ts Score for Heparin-Induced Thrombocytopenia (HIT)

ISTH-SSC Bleeding Assessment Tool (ISTH-SCC BAT)

IMPEDE-VTE

ATRIA Bleeding Risk Score

CKD-EPI Equations for Glomerular Filtration Rate (GFR)

HAS-BLED Score for Major Bleed Risk

HEMORR2HAGES Score For Major Bleeding

CHA2DS2-VASc Score for Atrial Fibrillation Stroke Risk

Glasgow-Blatchford Bleeding Score (GBS)

Venous Thromboembolism Evaluation & Management in the Emergency Department

Aspirin Deprescribing Guidelines

Creatinine Clearance (Cockcroft-Gault Equation)

Creatinine Clearance (Cockcroft-Gault) Without BMI Adjustment

Also from EVAL Foundation

Alcohol Use Disorders Identification Test - C (AUDIT-C)

Alcohol Use Disorders Identification Test (AUDIT)

American Shoulder and Elbow Surgeons (ASES) Shoulder Score

Behavioral Activity Rating Scale (BARS)

Drug Abuse Screening Test (DAST-10)

Foot and Ankle Ability Measure (FAAM)

Foot and Ankle Disability Index (FADI)

General Anxiety Disorder (GAD-7)